Emerald Advisers’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Emerald Advisers’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,875	Closed	-$43K	–	273
2017 Q3	$43K	Hold	10,875	–	–	﹤0.01%	236
2017 Q2	$55K	Hold	10,875	–	–	﹤0.01%	223
2017 Q1	$75K	Sell	10,875 -272,676	-96%	-$2.13M	﹤0.01%	230
2016 Q4	$2.65M	Sell	283,551 -6,495	-2%	-$58.5K	0.11%	139
2016 Q3	$2.84M	Sell	290,046 -738	-0.3%	-$9.96K	0.13%	184
2016 Q2	$4.11M	Sell	290,784 -11,080	-4%	-$173K	0.2%	138
2016 Q1	$4.22M	Buy	301,864 +117,254	+64%	+$1.72M	0.21%	136
2015 Q4	$3.77M	Buy	+184,610	New	+$2.85M	0.18%	147

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

Emerald Advisers's AGTC Position: Q4 2017 in Review

Emerald Advisers sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2017, closing a stake of 10,875 shares — an estimated $43K sold.

Emerald Advisers first reported a position in AGTC in Q4 2015 and held it in 8 quarters. The position peaked at $4.22M in Q1 2016. 62 funds tracked by Wall St. Rank hold AGTC as of Q4 2017.

Emerald Advisers reported no remaining Applied Genetic Technologies Corporation position as of Q4 2017 after selling out during the quarter.
Emerald Advisers sold 10,875 Applied Genetic Technologies Corporation shares in Q4 2017, an estimated $43K.
Emerald Advisers first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 8 quarters.
Emerald Advisers's Applied Genetic Technologies Corporation position peaked at $4.22M in Q1 2016.
62 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2017.

Based on Emerald Advisers's 13F filing for Q4 2017, filed 5 Feb 2018.